We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · December 24, 2020

Immune Checkpoint-Mediated Psoriasis

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Immune Checkpoint-Mediated Psoriasis: A Multicentric European Study of 115 Patients From European Network for Cutaneous ADverse Event to Oncologic Drugs (ENCADO) Group
J Am Acad Dermatol 2020 Dec 03;[EPub Ahead of Print], V Nikolaou, V Sibaud, D Fattore, P Sollena, A Ortiz-Brugués, D Giacchero, MC Romano, J Riganti, K Lallas, K Peris, D Voudouri, A Lallas, G Fabbrocini, E Lazaridou, C Carrera, MC Annunziata, E Rossi, A Patri, D Rigopoulos, AJ Stratigos, Z Apalla

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading